Pickhardt P J, Siegel M J, Anderson D C, Hayashi R, DeBaun M R
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
AJR Am J Roentgenol. 1998 Aug;171(2):375-82. doi: 10.2214/ajr.171.2.9694455.
The radiologic findings of posttransplantation lymphoproliferative disorder in lung transplant recipients have received little attention compared with the findings for recipients of other solid organ transplants. We describe the intrathoracic findings and explore whether the radiographic presentation can predict outcome.
Twenty-six patients (mean age, 32 years; range, 2-63 years; 18 female, eight male) with histologically proven lymphoproliferative disorder were identified from 518 lung transplantation patients, a 5.0% frequency. Chest radiographs, obtained within 1 week of diagnosis, were compared with baseline posttransplantation radiographs for all 26 patients and with chest CT scans for 20 patients.
The interval between transplantation and diagnosis ranged from 6 weeks to 7 years (mean, 16 months; median, 6 months). The thorax was involved in 18 (69%) of 26 patients. A new chest radiographic abnormality was present in all 18 patients and provided the first indication of disease in 14 (78%) of 18 patients. The most common finding was a solitary pulmonary nodule, seen in nine (50%) of 18 patients. Other findings included multiple nodules, multifocal alveolar infiltrates, and hilar and mediastinal adenopathy. CT scans detected additional nodules and lymph nodes but did not show occult disease in any case that appeared normal on radiography. Eight (89%) of nine patients with solitary pulmonary nodules at presentation were alive 1 year after diagnosis, compared with six (35%) of 17 patients with other presentations (p < .01).
Thoracic manifestations are present in most lung transplant recipients with lymphoproliferative disorder. Patients with solitary nodules have a better outcome in the first year after diagnosis than do patients with other presentations.
与其他实体器官移植受者的情况相比,肺移植受者移植后淋巴细胞增生性疾病的放射学表现很少受到关注。我们描述胸腔内的表现,并探讨影像学表现是否能预测预后。
从518例肺移植患者中识别出26例经组织学证实为淋巴细胞增生性疾病的患者(平均年龄32岁,范围2 - 63岁;18例女性,8例男性),发生率为5.0%。在诊断后1周内获取的胸部X线片与所有26例患者的移植后基线X线片进行比较,并与20例患者的胸部CT扫描结果进行比较。
移植与诊断之间的间隔时间为6周至7年(平均16个月,中位数6个月)。26例患者中有18例(69%)胸部受累。18例患者均出现新的胸部X线异常,其中14例(78%)的这一异常是疾病的首个迹象。最常见的表现是孤立性肺结节,18例患者中有9例(50%)出现。其他表现包括多发结节、多灶性肺泡浸润以及肺门和纵隔淋巴结肿大。CT扫描检测到了更多结节和淋巴结,但在任何X线表现正常的病例中均未显示隐匿性疾病。9例初诊时有孤立性肺结节的患者中有8例(89%)在诊断后1年存活,而17例有其他表现的患者中有6例(35%)存活(p <.01)。
大多数患有淋巴细胞增生性疾病的肺移植受者有胸部表现。初诊时有孤立性结节的患者在诊断后的第一年预后比有其他表现的患者更好。